• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

将抗生素与噬菌体联合使用以控制细菌病原体铜绿假单胞菌的机遇之窗。

A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.

作者信息

Torres-Barceló Clara, Arias-Sánchez Flor I, Vasse Marie, Ramsayer Johan, Kaltz Oliver, Hochberg Michael E

机构信息

Institut des Sciences de l'Evolution, CNRS-Université Montpellier 2, Montpellier, France.

Institut des Sciences de l'Evolution, CNRS-Université Montpellier 2, Montpellier, France; Santa Fe Institute, Santa Fe, New Mexico, United States of America; Wissenshaftskolleg zu Berlin, Berlin, Germany.

出版信息

PLoS One. 2014 Sep 26;9(9):e106628. doi: 10.1371/journal.pone.0106628. eCollection 2014.

DOI:10.1371/journal.pone.0106628
PMID:25259735
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4178015/
Abstract

The evolution of antibiotic resistance in bacteria is a global concern and the use of bacteriophages alone or in combined therapies is attracting increasing attention as an alternative. Evolutionary theory predicts that the probability of bacterial resistance to both phages and antibiotics will be lower than to either separately, due for example to fitness costs or to trade-offs between phage resistance mechanisms and bacterial growth. In this study, we assess the population impacts of either individual or combined treatments of a bacteriophage and streptomycin on the nosocomial pathogen Pseudomonas aeruginosa. We show that combining phage and antibiotics substantially increases bacterial control compared to either separately, and that there is a specific time delay in antibiotic introduction independent of antibiotic dose, that minimizes both bacterial density and resistance to either antibiotics or phage. These results have implications for optimal combined therapeutic approaches.

摘要

细菌对抗生素耐药性的演变是一个全球关注的问题,单独使用噬菌体或在联合治疗中使用噬菌体作为一种替代方法正受到越来越多的关注。进化理论预测,细菌对噬菌体和抗生素同时产生耐药性的可能性将低于对两者单独产生耐药性的可能性,例如,这是由于适应度成本或噬菌体耐药机制与细菌生长之间的权衡。在本研究中,我们评估了噬菌体和链霉素单独或联合处理对医院病原体铜绿假单胞菌的群体影响。我们表明,与单独使用相比,噬菌体和抗生素联合使用可显著增强对细菌的控制,并且在不考虑抗生素剂量的情况下,抗生素引入存在特定的时间延迟,这可将细菌密度以及对抗生素或噬菌体的耐药性降至最低。这些结果对最佳联合治疗方法具有启示意义。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/3bbcbe0cd714/pone.0106628.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/7f6cd4ec16b2/pone.0106628.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/3b8e293bf4bb/pone.0106628.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/bba4e86a8a29/pone.0106628.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/3bbcbe0cd714/pone.0106628.g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/7f6cd4ec16b2/pone.0106628.g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/3b8e293bf4bb/pone.0106628.g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/bba4e86a8a29/pone.0106628.g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0f43/4178015/3bbcbe0cd714/pone.0106628.g004.jpg

相似文献

1
A window of opportunity to control the bacterial pathogen Pseudomonas aeruginosa combining antibiotics and phages.将抗生素与噬菌体联合使用以控制细菌病原体铜绿假单胞菌的机遇之窗。
PLoS One. 2014 Sep 26;9(9):e106628. doi: 10.1371/journal.pone.0106628. eCollection 2014.
2
Combinations of Bacteriophage Are Efficacious against Multidrug-Resistant and Enhance Sensitivity to Carbapenem Antibiotics.噬菌体组合对多药耐药菌有效,并增强对碳青霉烯类抗生素的敏感性。
Viruses. 2024 Jun 21;16(7):1000. doi: 10.3390/v16071000.
3
Optimizing bacteriophage treatment of resistant .优化噬菌体治疗耐药菌。
mSphere. 2024 Jul 30;9(7):e0070723. doi: 10.1128/msphere.00707-23. Epub 2024 Jun 27.
4
Targeting Pseudomonas aeruginosa biofilm with an evolutionary trained bacteriophage cocktail exploiting phage resistance trade-offs.利用噬菌体耐药权衡开发经过进化训练的噬菌体鸡尾酒靶向铜绿假单胞菌生物膜。
Nat Commun. 2024 Oct 3;15(1):8572. doi: 10.1038/s41467-024-52595-w.
5
The uncharacterized PA3040-3042 operon is part of the cell envelope stress response and a tobramycin resistance determinant in a clinical isolate of .未鉴定的PA3040 - 3042操纵子是细胞包膜应激反应的一部分,也是一种临床分离株中妥布霉素抗性的决定因素。
Microbiol Spectr. 2024 Aug 6;12(8):e0387523. doi: 10.1128/spectrum.03875-23. Epub 2024 Jul 1.
6
Improving the Inhibitory Effect of Phages against Isolated from a Burn Patient Using a Combination of Phages and Antibiotics.利用噬菌体和抗生素联合使用提高对烧伤患者分离噬菌体的抑制效果。
Viruses. 2021 Feb 21;13(2):334. doi: 10.3390/v13020334.
7
Bacteriophages and Their Clinical Applications.噬菌体及其临床应用。
Viruses. 2024 Jun 29;16(7):1051. doi: 10.3390/v16071051.
8
Effect of bacteriophage infection in combination with tobramycin on the emergence of resistance in Escherichia coli and Pseudomonas aeruginosa biofilms.噬菌体感染联合妥布霉素对大肠杆菌和铜绿假单胞菌生物膜中耐药性产生的影响。
Viruses. 2014 Oct 3;6(10):3778-86. doi: 10.3390/v6103778.
9
Protect thy host: Pf4 phages shield Pseudomonas aeruginosa from antibiotics.保护宿主:Pf4 噬菌体保护铜绿假单胞菌免受抗生素侵害。
Environ Microbiol. 2020 Jul;22(7):2461-2462. doi: 10.1111/1462-2920.15046. Epub 2020 May 14.
10
Phage-antibiotic synergism: a possible approach to combatting Pseudomonas aeruginosa.噬菌体-抗生素协同作用:一种对抗铜绿假单胞菌的可能方法。
Res Microbiol. 2013 Jan;164(1):55-60. doi: 10.1016/j.resmic.2012.08.008. Epub 2012 Sep 7.

引用本文的文献

1
Lytic bacteriophages targeting multidrug-resistant Pseudomonas aeruginosa in Moschus berezovskii: isolation, characterization, and therapeutic efficacy against bacteremia.靶向马麝体内耐多药铜绿假单胞菌的裂解性噬菌体:分离、鉴定及对菌血症的治疗效果
Virol J. 2025 Aug 19;22(1):285. doi: 10.1186/s12985-025-02715-9.
2
Marine Bacteriophages as Next-Generation Therapeutics: Insights into Antimicrobial Potential and Application.海洋噬菌体作为下一代治疗药物:对抗菌潜力与应用的见解
Viruses. 2025 Jul 10;17(7):971. doi: 10.3390/v17070971.
3
Combined Forces Against Bacteria: Phages and Antibiotics.

本文引用的文献

1
Back to the future: evolving bacteriophages to increase their effectiveness against the pathogen Pseudomonas aeruginosa PAO1.回到未来:进化噬菌体以提高其对抗病原菌铜绿假单胞菌 PAO1 的效力。
Evol Appl. 2013 Nov;6(7):1054-63. doi: 10.1111/eva.12085. Epub 2013 Jul 15.
2
Revenge of the phages: defeating bacterial defences.噬菌体的复仇:击败细菌防御
Nat Rev Microbiol. 2013 Oct;11(10):675-87. doi: 10.1038/nrmicro3096. Epub 2013 Aug 27.
3
Evolutionary rescue in populations of Pseudomonas fluorescens across an antibiotic gradient.
对抗细菌的联合力量:噬菌体与抗生素
Health Sci Rep. 2025 Jul 9;8(7):e70956. doi: 10.1002/hsr2.70956. eCollection 2025 Jul.
4
The Current Landscape of Phage-Antibiotic Synergistic (PAS) Interactions.噬菌体 - 抗生素协同(PAS)相互作用的当前态势
Antibiotics (Basel). 2025 May 27;14(6):545. doi: 10.3390/antibiotics14060545.
5
In vitro activity of cefiderocol against Gram-negative aerobic bacilli in planktonic and biofilm form-alone and in combination with bacteriophages.头孢地尔对浮游态和生物被膜态革兰氏阴性需氧杆菌的体外活性——单独及与噬菌体联合使用时的情况
Sci Rep. 2025 May 16;15(1):17105. doi: 10.1038/s41598-025-01704-w.
6
Unravelling the Antibiotic Resistance: Molecular Insights and Combating Therapies.解析抗生素耐药性:分子见解与对抗疗法
Appl Biochem Biotechnol. 2025 Feb 18. doi: 10.1007/s12010-025-05182-8.
7
Chloramphenicol and gentamicin reduce the evolution of resistance to phage ΦX174 by suppressing a subset of E. coli LPS mutants.氯霉素和庆大霉素通过抑制一部分大肠杆菌脂多糖突变体来减少对噬菌体ΦX174的抗性演变。
PLoS Biol. 2025 Jan 21;23(1):e3002952. doi: 10.1371/journal.pbio.3002952. eCollection 2025 Jan.
8
Advancing Phage Therapy: A Comprehensive Review of the Safety, Efficacy, and Future Prospects for the Targeted Treatment of Bacterial Infections.推进噬菌体疗法:针对细菌感染靶向治疗的安全性、有效性及未来前景的全面综述
Infect Dis Rep. 2024 Nov 28;16(6):1127-1181. doi: 10.3390/idr16060092.
9
Long-Term Effectiveness of Engineered T7 Phages Armed with Silver Nanoparticles Against Biofilm.携载银纳米颗粒的工程化 T7 噬菌体对抗生物膜的长期有效性
Int J Nanomedicine. 2024 Oct 4;19:10097-10105. doi: 10.2147/IJN.S479960. eCollection 2024.
10
Engineered bacteriophages: A panacea against pathogenic and drug resistant bacteria.工程噬菌体:对抗致病性和耐药性细菌的万灵药。
Heliyon. 2024 Jul 9;10(14):e34333. doi: 10.1016/j.heliyon.2024.e34333. eCollection 2024 Jul 30.
在抗生素梯度中对荧光假单胞菌种群进行进化拯救。
Evol Appl. 2013 Jun;6(4):608-16. doi: 10.1111/eva.12046. Epub 2013 Feb 4.
4
The role of the immune system in governing host-microbe interactions in the intestine.免疫系统在调节肠道中宿主-微生物相互作用中的作用。
Nat Immunol. 2013 Jul;14(7):660-7. doi: 10.1038/ni.2611.
5
Phage cocktails and the future of phage therapy.噬菌体鸡尾酒和噬菌体治疗的未来。
Future Microbiol. 2013 Jun;8(6):769-83. doi: 10.2217/fmb.13.47.
6
Antibiotics and antibiotic resistance: a bitter fight against evolution.抗生素与抗生素耐药性:一场与进化的苦战。
Int J Med Microbiol. 2013 Aug;303(6-7):293-7. doi: 10.1016/j.ijmm.2013.02.004. Epub 2013 Mar 19.
7
Treatment, promotion, commotion: antibiotic alternatives in food-producing animals.治疗、促进、骚动:食用动物中的抗生素替代品。
Trends Microbiol. 2013 Mar;21(3):114-9. doi: 10.1016/j.tim.2012.11.001.
8
Emerging therapies for multidrug resistant Acinetobacter baumannii.多药耐药鲍曼不动杆菌的新兴治疗方法。
Trends Microbiol. 2013 Mar;21(3):157-63. doi: 10.1016/j.tim.2012.12.002. Epub 2013 Jan 11.
9
The probability of evolutionary rescue: towards a quantitative comparison between theory and evolution experiments.进化拯救的可能性:理论与进化实验的定量比较。
Philos Trans R Soc Lond B Biol Sci. 2013 Jan 19;368(1610):20120088. doi: 10.1098/rstb.2012.0088.
10
Concentration-resistance relationships with Pseudomonas aeruginosa exposed to doripenem and ciprofloxacin in an in vitro model.在体外模型中研究铜绿假单胞菌对多利培南和环丙沙星的浓度耐药关系。
J Antimicrob Chemother. 2013 Apr;68(4):881-7. doi: 10.1093/jac/dks463. Epub 2012 Nov 21.